Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report

Por Dennis Christoph Harrer, Karin Menhart, Stephanie Mayer, Wolfgang Herr, Albrecht Reichle, Martin Vogelhuber
Publicado em 2020-10-01